Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension

NCT00555880 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypotension, Orthostatic

Interventions

DRUG: Midodrine hydrochloride
DRUG: Placebo

Sponsor

Shire